An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 065013
Company: XGEN PHARMS

Products on ANDA 065013

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TOBRAMYCIN SULFATE	TOBRAMYCIN SULFATE	EQ 1.2GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	AP	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 065013

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/17/2001	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/29/2023	SUPPL-17	Labeling-Package Insert		Label is not available on this site.
02/10/2023	SUPPL-16	Labeling-Package Insert		Label is not available on this site.
08/16/2013	SUPPL-12	Labeling-Package Insert		Label is not available on this site.
11/09/2012	SUPPL-11	Labeling-Package Insert		Label is not available on this site.
10/07/2013	SUPPL-10	Labeling		Label is not available on this site.
10/31/2012	SUPPL-9	Labeling-Package Insert		Label is not available on this site.
10/18/2010	SUPPL-8	Labeling-Package Insert		Label is not available on this site.
01/17/2012	SUPPL-7	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/065013s007lbl.pdf
12/09/2002	SUPPL-2	Manufacturing (CMC)-Control		Label is not available on this site.

Labels for ANDA 065013

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/17/2012	SUPPL-7	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/065013s007lbl.pdf

Therapeutic Equivalents for ANDA 065013

TOBRAMYCIN SULFATE

INJECTABLE;INJECTION; EQ 1.2GM BASE/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
TOBRAMYCIN SULFATE	TOBRAMYCIN SULFATE	EQ 1.2GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	217519	EUGIA PHARMA
TOBRAMYCIN SULFATE	TOBRAMYCIN SULFATE	EQ 1.2GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	050789	FRESENIUS KABI USA
TOBRAMYCIN SULFATE	TOBRAMYCIN SULFATE	EQ 1.2GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	211189	GLAND
TOBRAMYCIN SULFATE	TOBRAMYCIN SULFATE	EQ 1.2GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	217029	SLATE RUN PHARMA
TOBRAMYCIN SULFATE	TOBRAMYCIN SULFATE	EQ 1.2GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	205685	XELLIA PHARMS APS
TOBRAMYCIN SULFATE	TOBRAMYCIN SULFATE	EQ 1.2GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	065013	XGEN PHARMS

Top